1 | (R)-[N-metil-11C1-PK11195(PK) | - | - | - | - | [1] 127 127 |
2 | 18-F]DPA-714 | - | - | - | - | [1] 127 127 |
3 | 18F-AV-1451 | - | - | - | - | [3] 5 5, 7, 127 |
4 | 18F-AV-45 | - | - | - | - | [2] 6 6, 127 |
5 | 18F-FDG | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [13] 5 5, 6, 7, 8, 13, 41, 46, 53, 84, 85, 96, 127, 300 |
6 | 18F-RO6958948 | - | - | - | - | [3] 5 5, 7, 127 |
7 | 18F]DPA-714 | - | - | - | - | [2] 13 13, 127 |
8 | [18F]PI-2620 | - | - | - | - | [2] 6 6, 127 |
9 | AL | - | - | - | - | [10] 5 5, 7, 13, 28, 51, 67, 86, 97, 114, 127 |
10 | AL001 | - | - | - | - | [2] 2 2, 127 |
11 | AMANTADINE | [1] Amantadine Amantadine | [2] D00777
D00777
,
D07441
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [4] 6 6, 8, 13, 127 |
12 | Amiodarone | [1] Amiodarone Amiodarone | [2] D00636
D00636
,
D02910
| [16] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [32] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 28 28, 127 |
13 | Amyvid | [1] Florbetapir (18F) Florbetapir (18F) | - | - | - | [2] 13 13, 127 |
14 | AV1451 Tau | - | - | - | - | [1] 127 127 |
15 | Behavioral: Cognitive and Behavioral experimental tasks | - | - | - | - | [2] 6 6, 127 |
16 | Behavioral: ECOCAPTURE | - | - | - | - | [2] 6 6, 127 |
17 | Behavioral: ICM_APATHY_TASKS | - | - | - | - | [2] 6 6, 127 |
18 | BIIB092 | - | - | - | - | [3] 5 5, 7, 127 |
19 | Blood sample | - | - | - | - | [18] 8 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299 |
20 | Brain PET scan | - | - | - | - | [3] 5 5, 7, 127 |
21 | C-11 PiB | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [1] 127 127 |
22 | Carbonate | [1] Carbonate ion Carbonate ion | - | - | - | [12] 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
23 | CENSAVUDINE | [1] Censavudine Censavudine | [1] D10550
D10550
| - | - | [2] 2 2, 127 |
24 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [29] 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338 |
25 | Citalopram | [1] Citalopram Citalopram | [2] D00822
D00822
,
D07704
| [1] SLC6A4 SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [7] 6 6, 8, 13, 18, 46, 98, 127 |
26 | Davunetide | [1] Davunetide Davunetide | [1] D09401
D09401
| - | - | [3] 5 5, 7, 127 |
27 | Davunetide (AL-108, NAP) | [1] Davunetide Davunetide | [1] D09401
D09401
| - | - | [3] 5 5, 7, 127 |
28 | Diagnostic Test: [18F]-RO6958948 | - | - | - | - | [5] 5 5, 6, 7, 17, 127 |
29 | Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau | - | - | - | - | [5] 5 5, 6, 7, 17, 127 |
30 | Diagnostic Test: Flutemetamol F18 Injection | [1] Flutemetamol (18F) Flutemetamol (18F) | - | - | - | [5] 5 5, 6, 7, 17, 127 |
31 | Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau | - | - | - | - | [5] 5 5, 6, 7, 17, 127 |
32 | Diagnostic Test: Neuropsychological assessment | - | - | - | - | [2] 6 6, 127 |
33 | Diagnostic Test: Supplementary Neuropsychological Assessment - Parkinson's Disease | - | - | - | - | [2] 6 6, 127 |
34 | DNL593 | - | - | - | - | [1] 127 127 |
35 | Donepezil | [1] Donepezil Donepezil | [2] D00670
D00670
,
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [9] 5 5, 6, 13, 46, 78, 124, 127, 156, 206 |
36 | DPA | - | - | - | - | [5] 2 2, 6, 13, 85, 127 |
37 | EVP-0334 | - | - | - | - | [1] 127 127 |
38 | F 18 T807 | - | - | - | - | [1] 127 127 |
39 | F-18 | - | - | - | - | [2] 5 5, 127 |
40 | F-18 FDG | - | - | - | - | [1] 127 127 |
41 | Ferulic acid | [1] Ferulic acid Ferulic acid | - | - | - | [1] 127 127 |
42 | Florbetapir (18F) | [1] Florbetapir (18F) Florbetapir (18F) | - | - | - | [1] 127 127 |
43 | Florbetapir 18F | - | - | - | - | [1] 127 127 |
44 | Florbetapir 18F Injection | - | - | - | - | [1] 127 127 |
45 | Flortaucipir | [1] Flortaucipir Flortaucipir | [1] D11210
D11210
| [1] MAPT MAPT 💬 | [4] Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | [3] 5 5, 7, 127 |
46 | Flortaucipir F18 | [1] Flortaucipir Flortaucipir | [1] D11210
D11210
| [1] MAPT MAPT 💬 | [4] Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | [3] 5 5, 7, 127 |
47 | Flutemetamol | [1] Flutemetamol (18F) Flutemetamol (18F) | - | - | - | [5] 5 5, 6, 7, 17, 127 |
48 | Flutemetamol F18 | [1] Flutemetamol (18F) Flutemetamol (18F) | - | - | - | [5] 5 5, 6, 7, 17, 127 |
49 | FRM-0334 | - | - | - | - | [1] 127 127 |
50 | GALANTAMINE | [1] Galantamine Galantamine | [2] D02173
D02173
,
D04292
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [2] 6 6, 127 |
51 | Galantamine hydrobromide | [1] Galantamine Galantamine | [2] D02173
D02173
,
D04292
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [2] 6 6, 127 |
52 | Histone Deacetylase Inhibitor | - | - | - | - | [1] 127 127 |
53 | Intranasal oxytocin | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [2] 127 127, 193 |
54 | Latozinemab | - | - | - | - | [1] 127 127 |
55 | Leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [11] 5 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299 |
56 | Leuco-methylthioninium bis(hydromethanesulfonate) | [1] Methylthioninium Methylthioninium | - | - | - | [1] 127 127 |
57 | LITHIUM CARBONATE | [2] Carbonate ion Carbonate ion, Lithium carbonate | [1] D00801
D00801
| - | - | [6] 2 2, 13, 17, 18, 19, 127 |
58 | LMTM | - | - | - | - | [1] 127 127 |
59 | LMTM/TRx0237 | - | - | - | - | [1] 127 127 |
60 | Lumbar Puncture | - | - | - | - | [6] 6 6, 13, 19, 96, 97, 127 |
61 | Memantine | [1] Memantine Memantine | [2] D04905
D04905
,
D08174
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [7] 2 2, 6, 8, 13, 49, 127, 205 |
62 | MEMANTINE HYDROCHLORIDE | [1] Memantine Memantine | [2] D04905
D04905
,
D08174
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [3] 2 2, 6, 127 |
63 | Metformin | [1] Metformin Metformin | [2] D00944
D00944
,
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [24] 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
64 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
65 | Methylthioninium | [1] Methylthioninium Methylthioninium | - | - | - | [1] 127 127 |
66 | Methylthioninium chloride | [3] Chloride ion Chloride ion, Methylene blue, Methylthioninium | [2] D02312
D02312
,
D10537
| - | - | [1] 127 127 |
67 | MTC TRx0014-001 capsules | - | - | - | - | [1] 127 127 |
68 | N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate) | [1] Phenothiazine Phenothiazine | [1] D02601
D02601
| - | - | [1] 127 127 |
69 | N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate) | [1] Phenothiazine Phenothiazine | [1] D02601
D02601
| - | - | [1] 127 127 |
70 | N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate) | [1] Phenothiazine Phenothiazine | [1] D02601
D02601
| - | - | [1] 127 127 |
71 | Neurohormonal mechanisms | - | - | - | - | [2] 6 6, 127 |
72 | Novolin-R insulin | - | - | - | - | [1] 127 127 |
73 | Open label - AL001 | - | - | - | - | [1] 127 127 |
74 | Other: 13C6 Leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [3] 5 5, 7, 127 |
75 | Other: MRI | - | - | - | - | [3] 6 6, 127, 206 |
76 | Oxytocin | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [6] 6 6, 72, 127, 193, 206, 226 |
77 | PBFT02 | - | - | - | - | [1] 127 127 |
78 | PEA-LUT | - | - | - | - | [1] 127 127 |
79 | Phenothiazine | [1] Phenothiazine Phenothiazine | [1] D02601
D02601
| - | - | [1] 127 127 |
80 | Pittsburgh Compound B | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [2] 6 6, 127 |
81 | Pittsburgh Compound B (C-11 PiB) | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [1] 127 127 |
82 | PR006 | - | - | - | - | [1] 127 127 |
83 | Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
84 | Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [49] 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
85 | ROTIGOTINE | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 6 6, 127 |
86 | Rotigotine 4Mg/24Hrs Patch | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 127 127 |
87 | Rotigotine 6Mg/24Hrs Patch | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 127 127 |
88 | Saline Nasal Mist | - | - | - | - | [1] 127 127 |
89 | Sirolimus | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [36] 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
90 | Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts | - | - | - | - | [2] 2 2, 127 |
91 | Syntocinon | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [3] 6 6, 127, 193 |
92 | T807 | - | - | - | - | [1] 127 127 |
93 | Tau (18-F-AV-1451) | - | - | - | - | [1] 127 127 |
94 | TOLCAPONE | [1] Tolcapone Tolcapone | [1] D00786
D00786
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [3] 6 6, 28, 127 |
95 | TPN-101 | - | - | - | - | [2] 2 2, 127 |
96 | TPN-101, 400 mg/day | - | - | - | - | [3] 2 2, 5, 127 |
97 | TRx0237 | - | - | - | - | [1] 127 127 |
98 | Verdiperstat | [1] Verdiperstat Verdiperstat | [1] D11684
D11684
| [1] MPO MPO 💬 | [5] Acute myeloid leukemia Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬 | [3] 2 2, 17, 127 |
99 | Vizamyl | [1] Flutemetamol (18F) Flutemetamol (18F) | - | - | - | [3] 5 5, 7, 127 |
100 | Vizamyl (flutemetamol(F-18)) | [1] Flutemetamol (18F) Flutemetamol (18F) | - | - | - | [3] 5 5, 7, 127 |
101 | WVE-004 | - | - | - | - | [2] 2 2, 127 |